FOS and neoplasm: rmCst6 and ZA treatment was found to decrease percentage of M0 and M4 macrophages, identified as early precursors of osteoclasts and tumor-associated macrophages with high expression of osteoclast differentiation regulators (Jun and c-Fos) [16,19].